



The mammary gland provides a unique window into funda-
mental developmental processes utilized by higher organ-
isms. In preparing to perform its critical role in milk
synthesis, the mammary gland must implement a co-
ordinated program involving proliferation and differentia-
tion of the secretory epithelium, utilization of fat stores
within the surrounding adipose tissue, and production of
milk proteins. The results of this postnatal developmental
process provide critical support for neonatal mammals,
and maternal investment in this process is critical for the
survival of the species. Once the young have been
weaned, however, it is no longer necessary to expend
such extensive resources on milk production. In a remark-
able reversal of the developmental transition that occurs
during pregnancy, the mammary gland undergoes an
equally coordinated process of involution that returns it to a
state superficially resembling that of the prepregnant gland.
Two papers in this issue of Breast Cancer Research [1,2]
provide new insights into the cellular and molecular details
of postlactational involution within the murine mammary
gland. Both groups utilized the ability of DNA microarray
technology to measure transcript abundance simultane-
ously from a substantial fraction of the genome. Previously
reported large-scale gene expression surveys of mammary
development spanning puberty, pregnancy, lactation, and
involution have been mined to identify not only individual
transcripts of known significance but also coordinately
regulated groups of genes from which functional path-
ways of importance in mammary gland physiology could
be inferred [3–5] (for a more detailed review of previous
microarray studies of murine mammary gland develop-
ment, see that by Master and Chodosh [6]). These new
contributions from the laboratories of Gusterson [1] and
Watson [2] both survey a greater number of genes during
mammary development and provide significantly greater
temporal resolution during involution than previous
microarray studies. In addition to providing satisfying con-
firmation of previous findings related to changes in the
physiology and cellular composition of the mammary gland
during involution, these studies provide a more intricate
view of the molecular details by which this remodeling
takes place.
Gene expression patterns during involution
Broadly speaking, mammary involution is known to
proceed in at least two stages, within which distinct, but
temporally overlapping, morphogenetic programs can be
identified [7,8]. The first involves the widespread apoptosis
of alveolar epithelial cells, thereby reversing the dramatic
expansion in this cellular compartment that occurs as a
consequence of pregnancy-induced lobuloalveolar
development. The second stage involves removal of the
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The developmental preparation of the mammary gland for milk production that occurs during
pregnancy is followed by an equally dramatic process of involution as the gland returns to its
prepregnancy state. Two detailed, microarray-based surveys reported in this issue extend our
understanding of the nature and timing of molecular and cellular events in involution that underlie these
developmental changes.
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resulting apoptotic debris as well as remodeling of the
extracellular matrix. Additionally, adipocytes regain their
substantial lipid stores such that the former morphologic
state of the gland is approximated.
Consistent with this biphasic model, a variety of gene
expression patterns during involution that reflect these
distinct morphogenetic stages have been described.
Strange and coworkers [7] provided the first detailed
description of gene expression changes in the involuting
mammary gland, including the induction of genes impli-
cated in stress response, tissue remodeling, and apoptotic
cell death. Subsequent microarray studies performed
nearly a decade later identified discrete clusters of genes
that are upregulated exclusively at day 2 or day 7 of involu-
tion, as well as clusters of genes that are upregulated at
both stages [4]. The former group included several genes
that had previously been associated with apoptosis during
early involution, such as Clu, Stat3, Igfbp5, and Cebpd
[7,9,10]. The latter group included gene expression clusters
that correspond to the degradation and remodeling of the
extracellular matrix that occurs during the second phase of
mammary gland involution. These consisted of changes in
the expression of several matrix metalloproteinases with
previously described roles in involution, as well as lysosomal
hydrolases [4,8]. Microarray approaches also revealed
marked differences in the expression of specific cathepsin
isoforms between day 2 and day 7 of involution [4]. Finally,
using nondirected computational approaches to identify
associations between clustered developmental expression
profiles and prospectively acquired functional gene
annotation, Master and coworkers [4] previously demon-
strated statistically significant overlap between genes
upregulated during early involution and thiol proteases,
zymogens, hydrolases, lysosomal enzymes, major histo-
compatibility complex components, and genes within the
complement pathway.
Despite these early insights, prior forays into gene expres-
sion profiling of this important developmental transition
generally lacked the temporal resolution required to
extend the undoubtedly primitive two-stage model of
mammary involution. The groups of Watson [2] and
Gusterson [1] now elegantly remedy this situation by
exploring in detail the temporal complexities of gene
expression and functional pathways that may be activated
during this period of profound morphologic change.
Although the broad outlines of the classic two-stage
model are supported by these new contributions, their
remarkable level of detail reveals a more intricate regula-
tion of cellular and molecular processes during involution.
For example, Clarkson and coworkers [2] note a general
trend in gene expression by which death receptor pathway
components are upregulated at the earliest time points
studied, whereas proapoptotic and antiapoptotic compo-
nents that influence the intrinsic mitochondrial contribution
to apoptosis (such as Bax, Mcl1, Bcl2l, and Apaf1) are
more highly expressed later in involution. This suggests, at
the very least, that transcriptional programs influencing the
early apoptotic stage of alveolar regression are not all acti-
vated simultaneously. Similarly, both groups describe the
expression of genes indicative of an acute phase
response; moreover, Clarkson and coworkers go on to
distinguish between an early class II acute phase
response and a later class I response that correlates with
Stat3, Cebpb, and Cebpd expression.
Although the detailed significance of these findings is as
yet unclear, they nevertheless suggest that each of the
broad stages of involution may ultimately be divided into a
number of discrete substages. Experimental manipulation
and analysis of these substages will probably yield further
insights into critical regulatory watersheds that exist in the
global program of involution as the gland reaches an irre-
versible ‘point of no return’.
Extending the biphasic model
More evidence for the complexity of involution is provided
by Clarkson and colleagues [2] through direct clustering
of gene expression profiles. They note three broad pat-
terns of change in gene expression during this time: a
rapid response within 12 hours after weaning, a moder-
ately delayed response at around 24 hours, and a slow
increase or decrease in gene expression over 3–4 days.
Interestingly, these patterns were observed both for
increases and decreases in gene expression. These data
demonstrate that, viewed from the perspective of gene
expression, one could reasonably argue for a conceptual
expansion from two to three phases of involution. Addi-
tional intricacies were noted in the long-term kinetics of
gene expression; for example, some genes in the rapidly
responding (12-hour) group exhibited only transient
changes in gene expression, whereas a smaller but signifi-
cant group exhibited altered expression levels through
96 hours. The authors then tested for statistically
significant associations between these patterns of gene
expression and prospective annotation derived from the
Gene Ontology consortium [11]. The ‘intracellular signal’
category, for example, was only significantly associated
with expression profiles that showed a rapid, transient
change in early involution. These types of analyses provide
additional support for the notion that the observed gene
expression profiles represent distinct cellular and meta-
bolic processes. Comparison with gene expression data
reported by Stein and coworkers [1] suggests that exam-
ining the longer term expression kinetics during involution
may further expand the classification of these profiles.
Immune cell recruitment in the mammary
gland
Analysis of these new gene expression data sets has con-
firmed the striking contribution of various immune cells to91
gene expression profiles during involution. Both groups
noted the expression of cytokines that may play a role in
recruiting immune cells to the gland.  Both groups also
describe the presence of a substantial macrophage popu-
lation in later involution, as was previously inferred from
microarray studies [4] and demonstrated by direct obser-
vation [12]. These cells are thought to play an important
role in the elimination of apoptotic debris [12]. However,
current reports suggest that the immunologic component
of the involuting gland is substantially more diverse than
debris-clearing monocytes or macrophages. For example,
Stein and coworkers [1] noted a marked increase in the
number of plasma cells between days 2 and 4 of involu-
tion, which is consistent with a previous description by
D’Cruz  and colleages [5] of increased κ light chain and
immunoglobulin heavy chain expressing cells at day 2 after
weaning in FVB mice. The large increase in immunoglobu-
lin gene expression, which was noted by both groups, was
correlated by Stein and coworkers with direct, morpho-
logic observations of plasma cells migrating from the
lymph node. Interestingly, although the presence of these
invading cells during involution might be presumed to be
transient, infiltrating immunoglobulin-producing cells have
been shown to be a persistent feature of the parous, invo-
luted gland that may be related to the well known protec-
tive relationship between parity and breast cancer risk
[5,13,14]. The cytokines identified by Stein and Clarkson
and coworkers may now shed further light on the basis for
this permanent change.
One discrepancy between this pair of studies relates to the
role of neutrophils in early involution. Both groups found
increased expression of Cxcl1, which encodes a neutrophil
attractant chemokine [15], early in involution. Consistent
with a functional role for this chemokine, Stein and cowork-
ers [1] noted a corresponding increase in LRG (leucine-
rich α2 glycoprotein) expression, presumably indicating the
presence of a neutrophil population [16]. This observation
was directly confirmed at the histologic level, although the
peak number of morphologically identified neutrophils
appeared in the gland at a time when LRG expression was
already decreasing. Thus, Stein and colleagues make a
strong case for a neutrophilic component in the immune
response of early involution, which is consistent with obser-
vations in a variety of other species [17]. In contrast,
despite confirming the early expression of Cxcl1, Clarkson
and coworkers [2] did not observe increases in any of a
variety of neutrophil-specific transcripts. As such, their
array results suggest an alternative model in which the
marked involutional upregulation of uterocalin – a known
inducer of neutrophil apoptosis – suppresses an increase
in acute inflammatory cells despite Cxcl1 signaling [18].
Several explanations may account for this difference. First,
these results may simply reflect a strain-specific difference
between Balb/c (as studied by Stein and coworkers [1])
and C57Bl/6 (as studied by Clarkson and coworkers [2])
mice. In this case, the data from Clarkson and colleagues
would demonstrate that a neutrophilic infiltrate is not func-
tionally required for involution to proceed. However,
because Clarkson and colleagues base their interpretation
on the lack of an increase in neutrophil-specific gene
expression, it remains a formal, if unlikely, possibility that
neutrophils are indeed recruited to the gland but exhibit
atypical transcriptional profiles. The issue of neutrophil flux
during involution will most easily be settled by quantitative,
histologic examination of other mouse strains in a manner
similar to that performed by Stein and colleagues. Never-
theless, these studies highlight an important caveat for
interpreting microarray studies of complex tissues. That is,
putative cell-specific markers – particularly those derived
from reports in the literature in other tissues or contexts –
need not always behave as expected. This point is made
most forcefully the observation by Stein and colleagues
that CD14 – a ‘monocyte-specific’ marker – is actually
expressed by the mammary epithelium. As such, these
papers highlight the critical importance of correlating
spatial and morphologic information with gene expression
data derived from homogenized complex tissues.
Conclusion
The enormous potential for microarray studies to generate
biologically relevant, mechanistic hypotheses of develop-
ment is beautifully confirmed by studies such as these
[1,2]. For example, manipulation of the chemokine signal-
ing pathways highlighted in these studies should allow a
direct assessment of their role in normal involution. A
better understanding of such details may help us to
unravel not only involution but also the behavior of
mammary epithelial cells during carcinogenesis. In addition
to the contribution that these studies make to our under-
standing of the complexities of mammary gland involution,
the availability of these and previous data sets for use by
the broader scientific community will undoubtedly facilitate
further insights and future work. In this regard, both
groups are to be commended for their efforts toward
placing these data sets in the public domain. Indeed, it is
the proliferation of data sets and analyses such as these
that will ultimately provide a truly molecular understanding of
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